Australia Stock Exchange release from KAZIA THERAPEUTI : Kazia enrols first patient to EVT801 Phase I clinical trial
03/11/2021 22:38
Australia Stock Exchange release from KAZIA THERAPEUTI KZA.AX : Kazia enrols first patient to EVT801 Phase I clinical trial
Recent news on Kazia Therapeutics
See all newsBrief: Kazia Therapeutics Files For Mixed Shelf Of Up To $100 Million – SEC Filing
Brief: Kazia Announces Voluntary Delisting From ASX
Australia's Kazia Therapeutics slumps to 1-yr low on delisting announcement
Brief: Kazia Therapeutics Announces Intention To Voluntarily De-List From ASX
Brief: Kazia Therapeutics Seeks Trading Halt